A. P. Auchus, MD, H. R. Brashear, MD, S. Salloway, MD, A. D. Korczyn, MD, P. P. De Deyn, MD, C. Gassmann-Mayer, PhD For the GAL-INT-26 Study Group From the Department of Neurology, University of Tennessee Health Science Center, and Memphis VAMC, Memphis, TN (A.P.A.); Johnson & Johnson Pharmaceutical Research and Development, L.L.C., La Jolla, CA (H.R.B., C.G.-M.); Director of Neurology and Th